XOMAP Q4 2021 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$36M+30.3% YoY

Gross Profit

$36M99.9% margin

Operating Income

$30M84.5% margin

Net Income

$30M83.0% margin

EPS (Diluted)

$2.63

QoQ Revenue Growth

+3723.9%

Cash Flow

Operating Cash Flow

$31M

Free Cash Flow

$31M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$167M

Total Liabilities

$25M

Stockholders' Equity

$142M

Cash & Equivalents

$93M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$36M	$28M	+30.3%
Gross Profit	$36M	$28M	+30.3%
Operating Income	$30M	$24M	+27.2%
Net Income	$30M	$23M	+31.7%